Jan Kyst Madsen, MD, DMSc

Original Contribution

Level of Complement Activity Predicts Cardiac Dysfunction after Acute Myocardial Infarction

01/06/2009

Helena Dominquez , MD, PhD;

Troels Krarup Hansen , MD, DMSc;

Jan Bech , MD, PhD;

Jan Kyst Madsen , MD, DMSc;

Jan Skov Jensen , MD, PhD, DMSc;

Peter Søgaard , MD, DMSc;

Sune Haahr-Pedersen , MD, PhD;

Mette Bjerre , PhD;

Søren Galatius , MD, DMSc;

Allan Flyvbjerg , MD, DMSc;

Rasmus Mogelvang , MD, PhD;

Treated with Primary Percutaneous Coronary Intervention ABSTRACT: Background. The positive effect of reperfusion after ST-elevation myocardial infarction (STEMI) can be reduced by ischemic/reperfusion (I/R) injury. Mannose-binding-lectin...

Treated with Primary...

01/06/2009

Journal of Invasive Cardiology

Original Contribution

Impact of Abciximab in Diabetic Patients with Acute Coronary Syndrome Who Undergo Percutaneous Coronary Intervention: Results from a High-Volume, Single-Center Registry

01/01/2011

Sune Haahr-Pedersen , MD, PhD;

Rasmus Mogelvang , MD, PhD;

Jan Kyst Madsen , MD, DMSc;

Allan Zeeberg Iversen , MD, PhD;

Jan Skov Jensen , MD, PhD, DMSc;

Christian Joens , MD, PhD;

Søren Galatius , MD, DMSc;

Anders Galloe , MD, PhD;

Ulrik Abildgaard , MD, DMSc;

Peter Riis Hansen , MD, PhD, DMSc;

NULL

01/01/2011

Journal of Invasive Cardiology

Original Contribution

Long-Term Clinical Outcome in STEMI Patients Treated With Primary PCI and Drug-Eluting or Bare-Metal Stents: Insights from a High-Volume Single-Center Registry

07/28/2011

Ulla Davidsen , MD;

Sune Haahr-Pedersen , MD, PhD;

Rasmus Mogelvang , MD, PhD;

Jan Bech , MD, PhD;

Jan Kyst Madsen , MD, DMSc;

Jan Skov Jensen , MD, PhD, DMSc;

Allan Zeeberg Iversen , MD, PhD;

Søren Galatius , MD, DMSc;

Anders Galloe , MD, PhD;

Ulrik Abildgaard , MD, DMSc;

Peter Riis Hansen , MD, PhD, DMSc;

Rikke Sorensen , MD, PhD;

Steen Zabell Abildstrom , MD, PhD;

Abstract: Objective. Use of drug-eluting stents (DES) in patients with ST-elevation myocardial infarction (STEMI) during routine primary percutaneous coronary intervention (pPCI) is controversial. Methods. From January 2004 to July 2008, a...

Abstract: Objective. Use of...

07/28/2011

Journal of Invasive Cardiology

Original Contribution

Significance of the Invasive Strategy After Acute Myocardial Infarction on Prognosis and Secondary Preventive Medication: A Nationwide Study of 6364 Women and 11,915 Men

01/05/2012

Søren Galatius , MD, DMSc;

Anders Hvelplund , MD;

Mette Madsen , MSc;

Rikke Sorensen , MD, PhD;

Hans-Henrik Tilsted , MD, PhD;

Steffen Helqvist , MD, PhD;

Poul Erik Mortensen , MD;

Per Hostrup Nielsen , MD;

Eva Prescott , MD, DMSc;

Steen Zabell Abildstrom , MD, PhD;

Jan Kyst Madsen , MD, DMSc;

Allan Zeeberg Iversen , MD, PhD;

Abstract: Objective. To describe gender-specific long-term outcome and initiation of secondary preventive medication among patients with acute myocardial infarction (AMI). Design. Observational cohort study. Setting. Nationwide registries....

Abstract: Objective. To describe...

01/05/2012

Journal of Invasive Cardiology

Original Contribution

Smokers With ST-Segment Elevation Myocardial Infarction and Short Time to Treatment Have Equal Effects of PCI and Fibrinolysis

07/30/2012

Thomas Rasmussen , MD;

Henning Kelbæk , MD;

Per Thayssen , MD;

Klaus Rasmussen , MD;

Leif Thuesen , MD;

Jan Kyst Madsen , MD, DMSc;

Lars Køber , MD;

Abstract: Objectives. The purpose of this study was to examine the effect of primary percutaneous coronary intervention (PCI) compared to fibrinolysis in smokers and non-smokers with ST-segment elevation myocardial infarction (STEMI). Smokers...

Abstract: Objectives. The...

07/30/2012

Journal of Invasive Cardiology